{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T07:04:19Z","timestamp":1766732659542,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PD\/BD\/114387\/2016","UID\/MULTI\/04046\/2019","UID\/MULTI\/04046\/2019"],"award-info":[{"award-number":["PD\/BD\/114387\/2016","UID\/MULTI\/04046\/2019","UID\/MULTI\/04046\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Familial hypercholesterolaemia increases circulating LDL-C levels and leads to premature cardiovascular disease when undiagnosed or untreated. Current guidelines support genetic testing in patients complying with clinical diagnostic criteria and cascade screening of their family members. However, most of hyperlipidaemic subjects do not present pathogenic variants in the known disease genes, and most likely suffer from polygenic hypercholesterolaemia, which translates into a relatively low yield of genetic screening programs. This study aims to identify new biomarkers and develop new approaches to improve the identification of individuals carrying monogenic causative variants. Using a machine-learning approach in a paediatric dataset of individuals, tested for disease causative genes and with an extended lipid profile, we developed new models able to classify familial hypercholesterolaemia patients with a much higher specificity than currently used methods. The best performing models incorporated parameters absent from the most common FH clinical criteria,\u00a0namely apoB\/apoA-I, TG\/apoB and LDL1. These parameters were found to contribute to an improved identification of monogenic individuals. Furthermore, models using only TC and LDL-C levels presented a higher specificity of classification when compared to simple cut-offs. Our results can be applied towards the improvement of the yield of genetic screening programs and corresponding costs.<\/jats:p>","DOI":"10.1038\/s41598-021-83392-w","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T14:31:41Z","timestamp":1613572301000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Machine learning modelling of blood lipid biomarkers in familial hypercholesterolaemia versus polygenic\/environmental dyslipidaemia"],"prefix":"10.1038","volume":"11","author":[{"given":"Marta","family":"Correia","sequence":"first","affiliation":[]},{"given":"Eva","family":"Kagenaar","sequence":"additional","affiliation":[]},{"given":"Dani\u00ebl Bernardus","family":"van Schalkwijk","sequence":"additional","affiliation":[]},{"given":"Mafalda","family":"Bourbon","sequence":"additional","affiliation":[]},{"given":"Margarida","family":"Gama-Carvalho","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"83392_CR1","doi-asserted-by":"crossref","unstructured":"M. W. Freeman, Lipid Metabolism and Coronary Artery Disease, in Principles of Molecular Medicine, 2nd edn., M. S. Runge and C. Patterson, Eds. Humana Press, Inc., 2006, pp. 130\u2013137.","DOI":"10.1007\/978-1-59259-963-9_15"},{"issue":"18","key":"83392_CR2","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","volume":"97","author":"PWF Wilson","year":"1998","unstructured":"Wilson, P. W. F. et al. Prediction of coronary heart disease using risk factor categories. Circulation 97(18), 1837\u20131847 (1998).","journal-title":"Circulation"},{"issue":"11","key":"83392_CR3","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.3390\/ijms19113426","volume":"19","author":"A Benito-Vicente","year":"2018","unstructured":"Benito-Vicente, A. et al. Familial hypercholesterolemia: the most frequent cholesterol metabolism disorder caused disease. Int. J. Mol. Sci. 19(11), 3426 (2018).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"83392_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41569-018-0052-6","volume":"16","author":"AJ Berberich","year":"2019","unstructured":"Berberich, A. J. & Hegele, R. A. The complex molecular genetics of familial hypercholesterolaemia. Nat. Rev. Cardiol. 16(1), 9\u201320 (2019).","journal-title":"Nat. Rev. Cardiol."},{"issue":"9","key":"83392_CR5","doi-asserted-by":"publisher","first-page":"e016461","DOI":"10.1136\/bmjopen-2017-016461","volume":"7","author":"LE Akioyamen","year":"2017","unstructured":"Akioyamen, L. E. et al. Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis. BMJ Open 7(9), e016461 (2017).","journal-title":"BMJ Open"},{"issue":"45","key":"83392_CR6","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","volume":"34","author":"BG Nordestgaard","year":"2013","unstructured":"Nordestgaard, B. G. et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society. Eur. Heart J. 34(45), 3478\u20133490 (2013).","journal-title":"Eur. Heart J."},{"issue":"1","key":"83392_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0021-9150(02)00330-1","volume":"168","author":"D Marks","year":"2003","unstructured":"Marks, D., Thorogood, M., Neil, H. A. W. & Humphries, S. E. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis 168(1), 1\u201314 (2003).","journal-title":"Atherosclerosis"},{"issue":"4","key":"83392_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/01.mol.0000137228.92396.f3","volume":"15","author":"J Rodenburg","year":"2004","unstructured":"Rodenburg, J. et al. Familial hypercholesterolemia in childhood: diagnostics, therapeutical options and risk stratification. Curr. Opin. Lipidol. 15(4), 405\u2013411 (2004).","journal-title":"Curr. Opin. Lipidol."},{"issue":"6","key":"83392_CR9","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","volume":"72","author":"AC Sturm","year":"2018","unstructured":"Sturm, A. C. et al. Clinical genetic testing for familial hypercholesterolemia. J. Am. Coll. Cardiol. 72(6), 662\u2013680 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"83392_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/MOL.0000000000000482","volume":"29","author":"JS Dron","year":"2018","unstructured":"Dron, J. S. & Hegele, R. A. Polygenic influences on dyslipidemias. Curr. Opin. Lipidol. 29(2), 133\u2013143 (2018).","journal-title":"Curr. Opin. Lipidol."},{"issue":"4","key":"83392_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/gim.2015.71","volume":"18","author":"AM Medeiros","year":"2016","unstructured":"Medeiros, A. M., Alves, A. C. & Bourbon, M. Mutational analysis of a cohort with clinical diagnosis of familial hypercholesterolemia: considerations for genetic diagnosis improvement. Genet. Med. 18(4), 316\u2013324 (2016).","journal-title":"Genet. Med."},{"issue":"5","key":"83392_CR12","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1194\/jlr.P043182","volume":"55","author":"AM Medeiros","year":"2014","unstructured":"Medeiros, A. M., Alves, A. C., Aguiar, P. & Bourbon, M. Cardiovascular risk assessment of dyslipidemic children: analysis of biomarkers to identify monogenic dyslipidemia. J. Lipid Res. 55(5), 947\u2013955 (2014).","journal-title":"J. Lipid Res."},{"issue":"2","key":"83392_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.atherosclerosis.2010.07.012","volume":"212","author":"AM Medeiros","year":"2010","unstructured":"Medeiros, A. M., Alves, A. C., Francisco, V. & Bourbon, M. Update of the Portuguese familial hypercholesterolaemia study. Atherosclerosis 212(2), 553\u2013558 (2010).","journal-title":"Atherosclerosis"},{"key":"83392_CR14","doi-asserted-by":"crossref","unstructured":"Scientific Steering Committee on behalf of the Simon Broome Register Group, Risk of fatal coronary heart disease in familial hypercholesterolaemia, BMJ, 303(6807), 893\u2013896, 1991.","DOI":"10.1136\/bmj.303.6807.893"},{"issue":"6","key":"83392_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/gim.2017.151","volume":"20","author":"JR Chora","year":"2018","unstructured":"Chora, J. R., Medeiros, A. M., Alves, A. C. & Bourbon, M. Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis. Genet. Med. 20(6), 591\u2013598 (2018).","journal-title":"Genet. Med."},{"issue":"2","key":"83392_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/clinchem\/47.2.266","volume":"47","author":"DM Hoefner","year":"2001","unstructured":"Hoefner, D. M. et al. Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Clin. Chem. 47(2), 266\u2013274 (2001).","journal-title":"Clin. Chem."},{"key":"83392_CR17","doi-asserted-by":"crossref","unstructured":"N. Clouet-Foraison, F. Gaie-Levrel, P. Gillery, & V. Delatour, Advanced lipoprotein testing for cardiovascular diseases risk assessment: a review of the novel approaches in lipoprotein profiling, Clin. Chem. Lab Med. 55(10) 2017.","DOI":"10.1515\/cclm-2017-0091"},{"key":"83392_CR18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cca.2012.09.010","volume":"414","author":"S Hirayama","year":"2012","unstructured":"Hirayama, S. & Miida, T. Small dense LDL: An emerging risk factor for cardiovascular disease. Clin. Chim. Acta 414, 215\u2013224 (2012).","journal-title":"Clin. Chim. Acta"},{"key":"83392_CR19","unstructured":"M. K. C. from Jed Wing et al., caret: Classification and Regression Training. 2018."},{"issue":"8","key":"83392_CR20","doi-asserted-by":"publisher","first-page":"e0182652","DOI":"10.1371\/journal.pone.0182652","volume":"12","author":"B Li","year":"2017","unstructured":"Li, B., Sharma, A., Meng, J., Purushwalkam, S. & Gowen, E. Applying machine learning to identify autistic adults using imitation: an exploratory study. PLoS ONE 12(8), e0182652 (2017).","journal-title":"PLoS ONE"},{"issue":"4","key":"83392_CR21","doi-asserted-by":"publisher","first-page":"e0175683","DOI":"10.1371\/journal.pone.0175683","volume":"12","author":"R Salvador","year":"2017","unstructured":"Salvador, R. et al. Evaluation of machine learning algorithms and structural features for optimal MRI-based diagnostic prediction in psychosis. PLoS ONE 12(4), e0175683 (2017).","journal-title":"PLoS ONE"},{"issue":"12","key":"83392_CR22","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.3390\/molecules22122086","volume":"22","author":"L Gao","year":"2017","unstructured":"Gao, L., Ye, M. & Wu, C. Cancer classification based on support vector machine optimized by particle swarm optimization and artificial bee colony. Molecules 22(12), 2086 (2017).","journal-title":"Molecules"},{"issue":"1","key":"83392_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s40168-018-0480-x","volume":"6","author":"L-G Li","year":"2018","unstructured":"Li, L.-G., Yin, X. & Zhang, T. Tracking antibiotic resistance gene pollution from different sources using machine-learning classification. Microbiome 6(1), 93 (2018).","journal-title":"Microbiome"},{"key":"83392_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jpeds.2015.11.018","volume":"170","author":"MA Eissa","year":"2016","unstructured":"Eissa, M. A., Mihalopoulos, N. L., Holubkov, R., Dai, S. & Labarthe, D. R. Changes in fasting lipids during puberty. J Pediatr 170, 199\u2013205 (2016).","journal-title":"J Pediatr"},{"issue":"1","key":"83392_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis, J. R. & Koch, G. G. The measurement of observer agreement for categorical data. Biometrics 33(1), 159\u2013174 (1977).","journal-title":"Biometrics"},{"key":"83392_CR26","first-page":"1","volume":"00","author":"F Mach","year":"2019","unstructured":"Mach, F. et al. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur. Heart J. 00, 1\u201378 (2019).","journal-title":"Eur. Heart J."},{"issue":"3","key":"83392_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2217\/clp.13.20","volume":"8","author":"I De Castro-Or\u00f3s","year":"2013","unstructured":"De Castro-Or\u00f3s, I., Pocov\u00ed, M. & Civeira, F. The fine line between familial and polygenic hypercholesterolemia. Clin. Lipidol. 8(3), 303\u2013306 (2013).","journal-title":"Clin. Lipidol."},{"key":"83392_CR28","first-page":"574","volume":"38","author":"E Ajufo","year":"2016","unstructured":"Ajufo, E. & Cuchel, M. Improving the yield of genetic testing in familial hypercholesterolaemia. Eur. Heart J. 38, 574\u2013576 (2016).","journal-title":"Eur. Heart J."},{"issue":"22","key":"83392_CR29","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","volume":"67","author":"AV Khera","year":"2016","unstructured":"Khera, A. V. et al. Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia. J. Am. Coll. Cardiol. 67(22), 2578\u20132589 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"83392_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.atherosclerosis.2019.12.005","volume":"294","author":"BG Nordestgaard","year":"2020","unstructured":"Nordestgaard, B. G. et al. Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM. Atherosclerosis 294, 46\u201361 (2020).","journal-title":"Atherosclerosis"},{"issue":"5","key":"83392_CR31","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/MOL.0000000000000114","volume":"25","author":"TA Lagace","year":"2014","unstructured":"Lagace, T. A. PCSK9 and LDLR degradation. Curr. Opin. Lipidol. 25(5), 387\u2013393 (2014).","journal-title":"Curr. Opin. Lipidol."},{"key":"83392_CR32","volume-title":"Assembly and Secretion of Atherogenic Lipoproteins","author":"C Beck","year":"2008","unstructured":"Beck, C. Assembly and Secretion of Atherogenic Lipoproteins (G\u00f6teborg University Sahlgrenska Academy, G\u00f6teborg, 2008)."},{"issue":"7","key":"83392_CR33","doi-asserted-by":"publisher","first-page":"e100376","DOI":"10.1371\/journal.pone.0100376","volume":"9","author":"DB van Schalkwijk","year":"2014","unstructured":"van Schalkwijk, D. B. et al. Dietary medium chain fatty acid supplementation leads to reduced VLDL lipolysis and uptake rates in comparison to linoleic acid supplementation. PLoS ONE 9(7), e100376 (2014).","journal-title":"PLoS ONE"},{"issue":"11","key":"83392_CR34","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1093\/aje\/kwn235","volume":"168","author":"GS Sagoo","year":"2008","unstructured":"Sagoo, G. S. et al. Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a huge association review and meta-analysis. Am. J. Epidemiol. 168(11), 1233\u20131246 (2008).","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"83392_CR35","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1172\/JCI112360","volume":"77","author":"B Teng","year":"1986","unstructured":"Teng, B., Sniderman, A. D., Soutar, A. K. & Thompson, G. R. Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia. J. Clin. Invest. 77(3), 663\u2013672 (1986).","journal-title":"J. Clin. Invest."},{"issue":"12","key":"83392_CR36","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1194\/jlr.M800354-JLR200","volume":"50","author":"DB van Schalkwijk","year":"2009","unstructured":"van Schalkwijk, D. B. et al. Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size. J. Lipid Res. 50(12), 2398\u20132411 (2009).","journal-title":"J. Lipid Res."},{"issue":"5","key":"83392_CR37","doi-asserted-by":"publisher","first-page":"718","DOI":"10.4161\/epi.27981","volume":"9","author":"S-P Guay","year":"2014","unstructured":"Guay, S.-P., Brisson, D., Lamarche, B., Gaudet, D. & Bouchard, L. Epipolymorphisms within lipoprotein genes contribute independently to plasma lipid levels in familial hypercholesterolemia. Epigenetics 9(5), 718\u2013729 (2014).","journal-title":"Epigenetics"},{"issue":"3","key":"83392_CR38","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.bbalip.2011.09.008","volume":"1821","author":"JD Brunzell","year":"2012","unstructured":"Brunzell, J. D., Zambon, A. & Deeb, S. S. The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1821(3), 365\u2013372 (2012).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83392-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83392-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83392-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:54:13Z","timestamp":1670039653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83392-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["83392"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-83392-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2021,2,15]]},"assertion":[{"value":"18 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3801"}}